Author

Ankush Chandra

The University of Texas Health Science Center at HoustonORCID 0000-0003-1843-3894Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Ankush Chandra1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Antonio DonoiD· 1 shared Austin ArrigoiD· 1 shared Chuling ZhuangiD· 1 shared Dongqin ZhuiD· 1 shared Hui‐Wen LoiD· 1 shared Jay‐Jiguang ZhuiD· 1 shared Mariana K. NajjariD· 1 shared Michael David ChaniD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Antonio DonoORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintFeb 20, 2025

Targeting tGLI1, a novel mediator of tumor therapeutic resistance, using Ketoconazole sensitizes glioblastoma to CDK4/6 therapy and Chemoradiation

Yu Pu Yang, Austin Arrigo, Ankush Chandra…·Hui‐Wen Lo

This paper identifies tGLI1 as a mediator of GBM resistance to CDK4/6 inhibitors and shows that ketoconazole sensitizes GBM to CDK4/6 therapy and chemoradiation.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky